These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7521151)

  • 41. High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-beta produced in yeast.
    Sedmak JJ; Grossberg SE
    J Interferon Res; 1989 Sep; 9 Suppl 1():S61-5. PubMed ID: 2809279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice.
    Koren S; Fleischmann WR
    J Interferon Res; 1986 Oct; 6(5):473-82. PubMed ID: 2433361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier.
    Wiranowska M; Wilson TC; Thompson K; Prockop LD
    J Interferon Res; 1989 Jun; 9(3):353-62. PubMed ID: 2746023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of interferon on C1300 mouse neuroblastoma.
    Tozawa M; Kidowaki T; Tanaka T; Sawada T; Kusunoki T; Oku T; Kishida T
    Cancer Treat Rep; 1982 Jul; 66(7):1575-7. PubMed ID: 6178506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism.
    Fleischmann WR; Koren S; Fleischmann CM
    Proc Soc Exp Biol Med; 1992 Nov; 201(2):200-7. PubMed ID: 1384066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of interferon-beta activity by fibroblast cells.
    Ramamurthy V; Fleischmann WR
    Antiviral Res; 1986 Aug; 6(5):267-75. PubMed ID: 3094445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-containing controlled-release polymers for localized cerebral immunotherapy.
    Wiranowska M; Ransohoff J; Weingart JD; Phelps C; Phuphanich S; Brem H
    J Interferon Cytokine Res; 1998 Jun; 18(6):377-85. PubMed ID: 9660244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-activated tumor inhibition in vivo. Small amounts of interferon-gamma inhibit tumor growth by eliciting host systemic immunoreactivity.
    Giovarelli M; Cofano F; Vecchi A; Forni M; Landolfo S; Forni G
    Int J Cancer; 1986 Jan; 37(1):141-8. PubMed ID: 3079742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumour effect of interferon combined with hyperthermia against experimental brain tumour.
    Kuroki M; Tanaka R; Hondo H
    Int J Hyperthermia; 1987; 3(6):527-34. PubMed ID: 3480323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A sensitive immunochemical assay for biologically active MuIFN-gamma.
    Curry RC; Kiener PA; Spitalny GL
    J Immunol Methods; 1987 Nov; 104(1-2):137-42. PubMed ID: 3119723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of mouse interferon-beta in normal and brain tumour-bearing mice.
    Mihara Y; Kuratsu J; Takaki S; Hori K; Nagai E; Satoh Y; Minowa N; Ushio Y
    Acta Neurochir (Wien); 1991; 109(1-2):46-51. PubMed ID: 2068966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of an ELISA bioassay for the routine titration of murine interferon-gamma.
    Le Moal MA; Motta I; Truffa-Bachi P
    Res Immunol; 1989; 140(5-6):613-24. PubMed ID: 2506615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemical modification of mouse interferons.
    Rusckowski M; Paucker M; Dalton B; Ogburn CA
    J Interferon Res; 1982; 2(2):177-85. PubMed ID: 6181175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages.
    Rollag H; Degré M
    Acta Pathol Microbiol Immunol Scand B; 1982 Dec; 90(6):389-95. PubMed ID: 7168315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gamma-interferon inhibits collagen synthesis in vivo in the mouse.
    Granstein RD; Murphy GF; Margolis RJ; Byrne MH; Amento EP
    J Clin Invest; 1987 Apr; 79(4):1254-8. PubMed ID: 3104404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial dissociation of antiviral and antimitogenic activities of murine interferon after its incorporation into liposomes.
    Eppstein DA; Marsh YV
    J Interferon Res; 1983; 3(2):161-8. PubMed ID: 6192185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of 830 nm low reactive level laser on the growth of an implanted glioma in mice.
    Abe M; Fujisawa K; Suzuki H; Sugimoto T; Kanno T
    Keio J Med; 1993 Dec; 42(4):177-9. PubMed ID: 8126974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lipoxygenase activation during the development of adaptation reactions in the body].
    Kosaganova NIu; Rikhireva GT
    Biofizika; 1989; 34(2):325-7. PubMed ID: 2545277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary observations on the pharmacokinetics of human lymphoblastoid interferon given by intramuscular injection.
    Priestman TJ; Johnston M; Whiteman PD
    Clin Oncol; 1982; 8(3):265-9. PubMed ID: 6183041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.